Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Wood-N-Tap
Getting hangry over a hidden delivery fee.
CATrends: Deceptive ‘Plant-Based’ Claims
A deceptive marketing trend takes root.
TINA.org Joins Over 300 Orgs. in Letter Urging Congress to Support Financial Watchdog
Legislators should protect the work of the Consumer Financial Protection Bureau.
Happy Howl Dog Food
What does “human-grade” dog food actually mean?
Plaintiffs Awarded $2.3 Million for Bigelow Made in USA Claim Steeped in Deception
The statement, “Manufactured in the USA 100%,” had appeared on product packaging.